BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 4, 2008
View Archived Issues
Telaprevir Takes Center Stage as New HCV Approaches Advance
As analysts predicted, the data coming out of embargo during the annual meeting of the American Association for the Study of Liver Disease (AASLD) don't appear to be triggering any major swings in biotech stock prices. (BioWorld Today)
Read More
Top FDA Career Officials Opposed Preemption Rules
Read More
Scientists Target Immune System Microenvironment to Strike Tumor
Read More
Genentech Seeks Avastin Use for Aggressive Brain Cancer
Read More
Avigen Cutting Staff 70% After Tolperisone Failure
Read More
Cephalon's Treanda OK'd for Second Cancer Indication
Read More
Clinic Roundup
Read More
Other News To Note
Read More